Industry News
NZ/UK collaboration for rapid point-of-care diagnostics
New Zealand biomarker research company BioTest Diagnostics is collaborating with UK diagnostics development company AgPlus to bring immediate point-of-care testing benefits to the veterinary market. [ + ]
iSonea raises $13.5m to fund AirSonea launch
iSonea (ASX:ISN) has raised $13.5m in a placement to help pay the manufacturing, distribution and marketing costs of the upcoming launch of mobile wheeze-monitoring device AirSonea. [ + ]
Bioniche closes funding, licensing deal with Paladin
Bioniche (ASX:BNC) has gained access to a further C$5m in funding after closing its debt refinancing and Urocidin licensing deal with Paladin Labs. [ + ]
Novogen gets up to $5m to fund CS-6 development
Novogen (ASX:NRT) has signed a deal with a US investor that will give it access to up to $5m in working capital to help take cancer drug candidate CS-6 into the clinic. [ + ]
The Australian Innovation Challenge 2013 is now open
The quest for the nation’s best ideas - in fields from minerals and energy to community services - resumes today through the $70,000 The Australian Innovation Challenge awards. [ + ]
Assay to ensure drugs reach their targets
Researchers at Karolinska Institutet in Sweden have developed the first method for directly measuring the extent to which drugs reach their targets in the cell. [ + ]
Why do antibiotics have side effects?
Over the years, doctors have prescribed antibiotics freely, thinking that they harm bacteria while leaving human tissue unscathed. But as scientists at Harvard University’s Wyss Institute for Biologically Inspired Engineering have noted, “Prolonged antibiotic treatment can lead to detrimental side effects in patients, including ototoxicity, nephrotoxicity and tendinopathy.” [ + ]
Novel chemistry for new class of antibiotic
University of Adelaide research has produced a potential new antibiotic which could help in the battle against bacterial resistance to antibiotics. [ + ]
Cheap antifreeze materials may lead to low-cost solar energy
A process combining some comparatively cheap materials and the same antifreeze that keeps an automobile radiator from freezing in cold weather may be the key to making solar cells that cost less and avoid toxic compounds. [ + ]
HIV treatment could reach millions more people
HIV-positive people are likely to gain increased access to antiretroviral treatment thanks to research showing that a lower dose is as effective as the standard higher dose. [ + ]
Prima doubles active sites for cancer vaccine trial
Prima BioMed (ASX:PRR) has started recruiting for its CANVAS ovarian cancer trial across four more European countries. [ + ]
Invest in science or fall behind
The Australian Academy of Science has launched its 2013 election policy that calls on the government to work with the science sector to build a long-term strategic vision for Australia’s future. [ + ]
University funding cuts to be re-examined
With the Australian National University announcing cuts to jobs, the new higher education minister plans to re-evaluate university funding [ + ]
pSivida initiates posterior uveitis trial
pSivida (ASX:PVA) has commenced recruitment for one of two planned US phase III trials of its injectable micro-insert in posterior uveitis. [ + ]
Review of employee share schemes announced
AusBiotech was pleased to learn that the government has announced it will review the policy settings around employee share schemes (ESS). [ + ]
